6622 — Zhaoke Ophthalmology Income Statement
0.000.00%
Last trade - 00:00- HK$1.60bn
- HK$839.97m
- CNY31.97m
Annual income statement for Zhaoke Ophthalmology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 18.8 | 69.3 | 32 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 14.2 | 51.8 | 16.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 364 | 404 | 395 | 297 | 232 |
| Operating Profit | -364 | -404 | -377 | -228 | -200 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2,130 | -407 | -384 | -237 | -209 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2,130 | -407 | -385 | -237 | -209 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2,130 | -407 | -385 | -237 | -209 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2,130 | -407 | -385 | -237 | -209 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.1 | -0.751 | -0.708 | -0.411 | -0.382 |